Diagnosis of breast cancer at dynamic MRI in patients with breast augmentation by paraffin or silicone injection

Diagnosis of breast cancer at dynamic MRI in patients with breast augmentation by paraffin or silicone injection
J.H. Youk, E.J. Son, E.-K. Kim, J.-A. Kim, M.J. Kim, J.Y. Kwak, S.M. Lee
Clinical Radiology
Volume 64, Issue 12, December 2009, Pages 1175-1180

Link to Journal

In patients with breasts injected with foreign material, MRI was used to successfully diagnose malignant breast lesions and could be the diagnostic method of choice. Analysis of the morphological and kinetic features at MRI in conjunction with clinical findings is essential.

(Ed..) If the patient has been injected with Silicone rather than paraffin oil, then add silicone suppression sequence to the fat suppression series to distinguish between foci of silicone and

Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-

Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
T. Arazi-Kleinman, P.A. Causer, R.A. Jong, K. Hill, E. Warner
Clinical Radiology Volume 64, Issue 12, December 2009, Pages 1166-1174

Link to Journal

The breast MRI CAD system used could not improve the radiologists' accuracy for distinguishing all malignant from benign lesions, due to the poor sensitivity for DCIS detection

Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?

Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?
L.J. Hamilton, A.J. Evans, E.J. Cornford, E.A. Rakha, I.O. Ellis, W.D. Foulkes
Clinical Radiology (2009) 64, 1045-1047

Link to Journal

Magnetic resonance imaging (MRI) screening for breast cancer has greater sensitivity than conventional mammographic screening.1,2 Digital mammography gives maximum sensitivity in younger women with denser breasts.3 Combining MRI with digital mammography is likely to give maximum sensitivity. This additional sensitivity offered by MRI has the potential to identify breast cancer at an earlier stage, when the tumours are smaller in size and are not associated with metastases to regional lymph nodes

It is of vital importance that actual mortality data on a cohort of MRI-screened BRCA1 carriers without prior breast cancer are published to en- able an informed decision on the benefits of MRI screening in this group. Until such mortality data are available, the predicted benefits must remain just that - predictions. We urge caution until such time as prospective survival data are available

Risk–benefit analysis of preoperative breast MRI in patients with primary breast cancer

Risk–benefit analysis of preoperative breast MRI in patients with primary breast cancer
K.C. Siegmann, A. Baur, U. Vogel, B. Kraemer, M. Hahn, C.D. Claussen
Clinical Radiology 2009 64(4): 403-413

Link to journal

119 patients undergoing pre-operative MRI of the breasts. The findings changed management in 48 patients (40.3%). The change in clinical management and patient benefit were independent of BD and TT (p > 0.05).
The percentage of additional biopsies of benign lesions was 10.1%

NB No difference in outcome between tumour types (rather unexpected)